Oral paracetamol in treatment of closure of patent ductus arteriosus in preterm neonates

Journal of Postgraduate Medicine

Volumn 59, Issue 4, 2013, Pages 312-314

  Jasani, B ^a   Kabra, N ^a   Nanavati, R N ^a  

^a KEM HOSPITAL   (India)

Author keywords

Paracetamol; patent ductus arteriosus; preterm neonates

Indexed keywords

CROCIN; IBUPROFEN; INDOMETACIN; PARACETAMOL; SURFACTANT;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLEEDING; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DUCTUS ARTERIOSUS OBLITERATION; ECHOCARDIOGRAPHY; HEART HEMODYNAMICS; HUMAN; HYPERBILIRUBINEMIA; INDIA; INFANT; KIDNEY FAILURE; NEWBORN INTENSIVE CARE; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; SEPSIS; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT RESPONSE;

ACETAMINOPHEN; ADMINISTRATION, ORAL; DUCTUS ARTERIOSUS, PATENT; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE;

EID: 84891942676     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.123164     Document Type: Article

References (13)

1. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2010;4:CD003481.
2. Neumann R, Schulzke SM, Bührer C. Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: A systematic review and meta-analysis. Neonatology. 2012;102:9-15.
3. Zecca E, Romagnoli C, De Carolis M, Costa S, Marra R, De Luca D. Does ibuprofen increase neonatal hyperbilirubinemia? Pediatrics. 2009;124:480-4.
4. Rheinlaender C, Helfenstein D, Walch E, Berns M, Obladen M, Koehne P. Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants. Acta Paediatr. 2009;98:36-42.
5. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: A surprising new approach to patent ductus arteriosus treatment. Pediatrics 2011; 128:e1618-21.
6. Green K, Drvota V, Vesterqvist O. Pronounced reduction of in vivo prostacyclin synthesis in humans by paracetamol. Prostaglandins. 1989;37:311-5.
7. Lucas R, Warner TD, Vojnovic I, Mitchell JA. Cellular mechanisms of acetaminophen: Role of cyclo-oxygenase. FASEB J. 2005;19:635-7.
8. Momma K, Takao A. Transplacental cardiovascular effects of four popular analgesics in rats. Am J Obstet Gynecol. 1990; 162:1304-10.
9. Peterson RG. Consequences associated with nonnarcotic analgesics in the fetus and newborn. Fed Proc. 1985;44:2309-13.
10. Simbi KA, Secchieri S, Rinaldo M, Demi M, Zanardo V. In utero ductal closure following near-term maternal self-medication with nimesulide and acetaminophen. J Obstet Gynaecol. 2002;22:440-5.
11. Oncel MY, Yurttutan S, Degirmencioglu H et al. Intravenous Paracetamol Treatment in the Management of Patent Ductus Arteriosus in Extremely Low Birth Weight Infants. Neonatology. 2012 Dec 19;103:166-9.
12. Yurttutan S, Oncel MY, Arayici S, Uras N, Altug N, Erdeve O, Dilmen U. A different first-choice drug in the medical management of patent ductus arteriosus: Oral paracetamol. J Matern Fetal Neonatal Med 2013 Jan 15. [Epub ahead of print]
13. Wilson-Smith EM, Morton NS. Survey of i.v. paracetamol (acetaminophen) use in neonates and infants under 1 year of age by UK anesthetists Paediatr Anaesth. 2009;19:329-37.